Selected(0)Clear
Items/Page: Sort: |
| Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms Journal article Pharmacology and Therapeutics, 2021,Volume: 219 Authors: Huang,Mu Yang; Jiang,Xiao Ming; Wang,Bing Lin; Sun,Yang; Lu,Jin Jian
 Favorite | | TC[WOS]:1 TC[Scopus]:1 | Submit date:2021/03/02 challenge combination therapy immunotherapy mechanism NSCLC PD-1/PD-L1 |
| Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms Journal article Pharmacology and Therapeutics, 2021,Volume: 219 Authors: Huang,Mu Yang; Jiang,Xiao Ming; Wang,Bing Lin; Sun,Yang; Lu,Jin Jian
 Favorite | | TC[WOS]:1 TC[Scopus]:1 | Submit date:2021/03/02 challenge combination therapy immunotherapy mechanism NSCLC PD-1/PD-L1 |
| Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells Journal article Phytomedicine, 2021,Volume: 80 Authors: Yuan,Luo Wei; Jiang,Xiao Ming; Xu,Yu Lian; Huang,Mu Yang; Chen,Yu Chi; Yu,Wei Bang; Su,Min Xia; Ye,Zi Han; Chen,Xiuping ; Wang,Yitao; Lu,Jin Jian
 Favorite | | TC[WOS]:0 TC[Scopus]:0 | Submit date:2021/03/01 IFN-γ Licochalcone A Natural products PD-L1 Protein synthesis inhibitor ROS |
| Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells Journal article Chinese Journal of Natural Medicines, 2020,Volume: 18,Issue: 7,Page: 517-525 Authors: CHEN,Yu Chi; HUANG,Mu Yang; ZHANG,Le Le; FENG,Zhe Ling; JIANG,Xiao Ming; YUAN,Luo Wei; HUANG,Run Yue; LIU,Bo; YU,Hua; WANG,Yi Tao; CHEN,Xiu Ping; LIN,Li Gen; LU,Jin Jian
 Favorite | | TC[WOS]:2 TC[Scopus]:2 | Submit date:2021/03/01 c-Jun JNK Lung cancer Nagilactone E Programmed death ligand 1 |
| Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity Journal article Acta Pharmacologica Sinica, 2020,Volume: 41,Issue: 5,Page: 698-705 Authors: Zhang,Le le; Guo,Jing; Jiang,Xiao ming; Chen,Xiu ping; Wang,Yi tao; Li,Ao; Lin,Li gen; Li,Hua; Lu,Jin jian
 Favorite | | TC[WOS]:6 TC[Scopus]:6 | Submit date:2021/03/01 Click-iT CMap diterpenoids human lung cancer A549 cell line xenograft molecular docking nagilactone E protein synthesis inhibitor RIOK2 RNA-seq |
| Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus Journal article Biochemical Pharmacology, 2020,Volume: 175 Authors: Li,Ting; Xu,Xiao Huang; Guo,Xia; Yuan,Tao; Tang,Zheng Hai; Jiang,Xiao Ming; Xu,Yu Lian; Zhang,Le Le; Chen,Xiuping ; Zhu,Hong; Shi,Jia Jie; Lu,Jin Jian
 Favorite | | TC[WOS]:2 TC[Scopus]:3 | Submit date:2021/03/01 Apoptosis c-MYC CHOP Lung cancer Notch 3 |
| Phanginin R induces cytoprotective autophagy via JNK/C-JUN signaling pathway in non-small cell lung cancer A549 cells Journal article Anti-Cancer Agents in Medicinal Chemistry, 2020,Volume: 20,Issue: 8,Page: 982-988 Authors: Zhang,Le Le; Bao,Han; Xu,Yu Lian; Jiang,Xiao Ming; Li,Wei; Zou,Liang; Lin,Li Gen; Lu,Jin Jian
 Favorite | | TC[WOS]:1 TC[Scopus]:2 | Submit date:2021/03/01 Anti-cancer Autophagy C-Jun JNK Non-small cell lung cancer Phanginin R |
| TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance Journal article Acta Pharmacologica Sinica, 2020 Authors: Jiang,Xiao ming; Xu,Yu lian; Yuan,Luo wei; Zhang,Le le; Huang,Mu yang; Ye,Zi han; Su,Min xia; Chen,Xiu ping; Zhu,Hong; Ye,Richard D.; Lu,Jin jian
 Favorite | | TC[WOS]:3 TC[Scopus]:2 | Submit date:2021/03/01 EGFR mutant non-small cell lung cancer epithelial-mesenchymal transition NF-κB osimertinib resistance TGFβ2 |
| Establishment and characterization of pemetrexed-resistant NCI-H460/PMT cells Journal article Anti-Cancer Agents in Medicinal Chemistry, 2019,Volume: 19,Issue: 6,Page: 731-739 Authors: Xu,Yu Lian; Jiang,Xiao Ming; Zhang,Le Le; Chen,Xiuping ; Huang,Zhang Jian; Lu,Jin Jian
 Favorite | | TC[WOS]:2 TC[Scopus]:2 | Submit date:2021/03/01 ABCB1 Chemotherapy NSCLC Pemetrexed Resistance TYMS |